Our objective was to determine if the insulin-sensitizing drug pioglitazone acutely reduces insulin secretion and causes metabolic deceleration in vivo independently of change in insulin sensitivity. We assessed glucose homeostasis by hyperinsulinemiceug
Hepatic insulin resistance is associated with hepatic steatosis and is thought to play an important ...
<p>The hippocampal CA1 area (a,b) and temporal cortex (e,f) in the control, and the pioglitazone-tre...
OBJECTIVE: To investigate the effects of pioglitazone and metformin treatment during pre-diabetic pe...
Our objective was to determine if the insulin-sensitizing drug pioglitazone acutely reduces insulin ...
Our objective was to determine if the insulin-sensitizing drug pioglitazone acutely reduces insulin ...
<p>Data are shown as mean ± S.E.M.</p>a<p><i>P</i><0.01,</p>b<p><i>P</i><0.01 versus control group;<...
Thiazolidinediones (TZDs) have beneficial effects on glucose homeostasis via enhancement of insulin ...
<p>Values are mean (+/− SD). Tests were performed as described in <a href="http://www.plosone.org/ar...
Type 2 diabetes and obesity are very serious health problems in both developed and developing countr...
Long-term pioglitazone treatment of rats ameliorates dyslipidemia and insulin resistance in muscle a...
Type 2 diabetes and obesity are very serious health problems in both developed and developing countr...
Pioglitazone (Pio) is a PPAR-γ agonist insulin sensitizer has anti-inflammatory activity. Our novel ...
OBJECTIVE - Diabetic hyperglycemia results from insulin resistance of peripheral tissues and glucose...
OBJECTIVE — Diabetic hyperglycemia results from insulin resistance of peripheral tissues and glucose...
Pioglitazone (PIO) is a peroxisome proliferator-activated receptor (PPAR)γ agonist insulin-sensitise...
Hepatic insulin resistance is associated with hepatic steatosis and is thought to play an important ...
<p>The hippocampal CA1 area (a,b) and temporal cortex (e,f) in the control, and the pioglitazone-tre...
OBJECTIVE: To investigate the effects of pioglitazone and metformin treatment during pre-diabetic pe...
Our objective was to determine if the insulin-sensitizing drug pioglitazone acutely reduces insulin ...
Our objective was to determine if the insulin-sensitizing drug pioglitazone acutely reduces insulin ...
<p>Data are shown as mean ± S.E.M.</p>a<p><i>P</i><0.01,</p>b<p><i>P</i><0.01 versus control group;<...
Thiazolidinediones (TZDs) have beneficial effects on glucose homeostasis via enhancement of insulin ...
<p>Values are mean (+/− SD). Tests were performed as described in <a href="http://www.plosone.org/ar...
Type 2 diabetes and obesity are very serious health problems in both developed and developing countr...
Long-term pioglitazone treatment of rats ameliorates dyslipidemia and insulin resistance in muscle a...
Type 2 diabetes and obesity are very serious health problems in both developed and developing countr...
Pioglitazone (Pio) is a PPAR-γ agonist insulin sensitizer has anti-inflammatory activity. Our novel ...
OBJECTIVE - Diabetic hyperglycemia results from insulin resistance of peripheral tissues and glucose...
OBJECTIVE — Diabetic hyperglycemia results from insulin resistance of peripheral tissues and glucose...
Pioglitazone (PIO) is a peroxisome proliferator-activated receptor (PPAR)γ agonist insulin-sensitise...
Hepatic insulin resistance is associated with hepatic steatosis and is thought to play an important ...
<p>The hippocampal CA1 area (a,b) and temporal cortex (e,f) in the control, and the pioglitazone-tre...
OBJECTIVE: To investigate the effects of pioglitazone and metformin treatment during pre-diabetic pe...